Qube Research & Technologies (QRT)
LFVN icon

Qube Research & Technologies (QRT)’s LifeVantage LFVN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,916
Closed -$815K – 3780
2025
Q1 		$815K Buy
55,916
+10,570
+23% +$199K ﹤0.01% 2348
2024
Q4 		$795K Buy
45,346
+31,084
+218% +$436K ﹤0.01% 2295
2024
Q3 		$172K Buy
14,262
+14,261
+1,426,100% +$118K ﹤0.01% 2633
2024
Q2 		$6 Sell
1
-387
-100% -$2.63K ﹤0.01% 3643
2024
Q1 		$2.35K Sell
388
-355
-48% -$2.24K ﹤0.01% 3982
2023
Q4 		$4.46K Buy
743
+742
+74,200% +$4.9K ﹤0.01% 3728
2023
Q3 		$6 Buy
+1
New +$6 ﹤0.01% 3958

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LFVN Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of LifeVantage (LFVN) in Q2 2025, closing a stake of 55,916 shares — an estimated $815K sold.

Qube Research & Technologies (QRT) first reported a position in LFVN in Q3 2023 and held it in 7 quarters. The position peaked at $815K in Q1 2025. 112 funds tracked by Wall St. Rank hold LFVN as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining LifeVantage position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 55,916 LifeVantage shares in Q2 2025, an estimated $815K.
  • Qube Research & Technologies (QRT) first reported a position in LifeVantage in Q3 2023 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s LifeVantage position peaked at $815K in Q1 2025.
  • 112 funds tracked by Wall St. Rank held LifeVantage as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.